d-4-chloro-17 beta-hydroxy-3-oxo-17 alpha-methylandrosta-1,4-diene has been researched along with buformin in 1 studies
*Buformin: An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation. [MeSH]
*Buformin: An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haller, H; Julius, U; Leonhardt, W; Schulze, J | 1 |
1 other study(ies) available for d-4-chloro-17 beta-hydroxy-3-oxo-17 alpha-methylandrosta-1,4-diene and buformin
| Article | Year |
|---|---|
[Metabolism kinetic characterization of hypertriglyceridemias in drug therapy variations].
Topics: Adult; Blood Glucose; Buformin; Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Delayed-Action Preparations; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Testosterone; Triglycerides | 1987 |